Sort by
Items per page

Send to

Choose Destination

Best matches for alzheimer's vegf:

VEGFR1 and VEGFR2 in Alzheimer's Disease. Harris R et al. J Alzheimers Dis. (2018)

Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease? Echeverria V et al. Curr Alzheimer Res. (2017)

Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection. Iram T et al. Neurobiol Dis. (2016)

Search results

Items: 1 to 20 of 250


Self-Reported Physical Activity and Relations to Growth and Neurotrophic Factors in Diabetes Mellitus: The Framingham Offspring Study.

Spartano NL, Davis-Plourde KL, Himali JJ, Murabito JM, Vasan RS, Beiser AS, Seshadri S.

J Diabetes Res. 2019 Jan 9;2019:2718465. doi: 10.1155/2019/2718465. eCollection 2019.


Impact of Metabolic Syndrome on Neuroinflammation and the Blood-Brain Barrier.

Van Dyken P, Lacoste B.

Front Neurosci. 2018 Dec 11;12:930. doi: 10.3389/fnins.2018.00930. eCollection 2018. Review.


Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.

Huynh MB, Ouidja MO, Chantepie S, Carpentier G, Maïza A, Zhang G, Vilares J, Raisman-Vozari R, Papy-Garcia D.

PLoS One. 2019 Jan 4;14(1):e0209573. doi: 10.1371/journal.pone.0209573. eCollection 2019.


VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells.

Singh Angom R, Wang Y, Wang E, Pal K, Bhattacharya S, Watzlawik JO, Rosenberry TL, Das P, Mukhopadhyay D.

FASEB J. 2018 Dec 21:fj201802003R. doi: 10.1096/fj.201802003R. [Epub ahead of print]


The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice.

Wang F, Feng J, Yang Y, Liu J, Liu M, Wang Z, Pei H, Wei Y, Li H.

Neuropsychiatr Dis Treat. 2018 Nov 9;14:3037-3051. doi: 10.2147/NDT.S175484. eCollection 2018.


Sub-Toxic Human Amylin Fragment Concentrations Promote the Survival and Proliferation of SH-SY5Y Cells via the Release of VEGF and HspB5 from Endothelial RBE4 Cells.

Caruso G, Fresta CG, Lazzarino G, Distefano DA, Parlascino P, Lunte SM, Lazzarino G, Caraci F.

Int J Mol Sci. 2018 Nov 20;19(11). pii: E3659. doi: 10.3390/ijms19113659.


Humanin Nanoparticles for Reducing Pathological Factors Characteristic of Age-Related Macular Degeneration.

Solanki A, Smalling R, Parola AH, Nathan I, Kasher R, Pathak Y, Sutariya V.

Curr Drug Deliv. 2019;16(3):226-232. doi: 10.2174/1567201815666181031163111.


Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults.

Raman MR, Himali JJ, Conner SC, DeCarli C, Vasan RS, Beiser AS, Seshadri S, Maillard P, Satizabal CL.

Stroke. 2018 Sep;49(9):2227-2229. doi: 10.1161/STROKEAHA.118.022613.


Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.

Youdim MBH.

J Neural Transm (Vienna). 2018 Nov;125(11):1719-1733. doi: 10.1007/s00702-018-1942-9. Epub 2018 Oct 19. Review.


Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer's disease spectrum.

Wang Z, Zhou W, Zhou B, Zhang J; for Alzheimer’s Disease Neuroimaging Initiative.

Neurosci Lett. 2018 Nov 20;687:276-279. doi: 10.1016/j.neulet.2018.09.055. Epub 2018 Sep 29.


Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines.

Ott BR, Jones RN, Daiello LA, de la Monte SM, Stopa EG, Johanson CE, Denby C, Grammas P.

Front Aging Neurosci. 2018 Aug 21;10:245. doi: 10.3389/fnagi.2018.00245. eCollection 2018.


The Secretion from Neural Stem Cells Pretreated with Lycopene Protects against tert-Butyl Hydroperoxide-Induced Neuron Oxidative Damage.

Huang C, Gan D, Fan C, Wen C, Li A, Li Q, Zhao J, Wang Z, Zhu L, Lu D.

Oxid Med Cell Longev. 2018 Jul 22;2018:5490218. doi: 10.1155/2018/5490218. eCollection 2018.


Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.

Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, Henry H, Oikonomidi A, Migliavacca E, Bacher M, Popp J.

Alzheimers Dement. 2018 Dec;14(12):1640-1650. doi: 10.1016/j.jalz.2018.06.2857. Epub 2018 Aug 14. Erratum in: Alzheimers Dement. 2019 Feb;15(2):319.


Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Du Y, Wu HT, Qin XY, Cao C, Liu Y, Cao ZZ, Cheng Y.

J Mol Neurosci. 2018 Jul;65(3):289-300. doi: 10.1007/s12031-018-1100-8. Epub 2018 Jun 28.


Alzheimer 's Disease: Possible Mechanisms Behind Neurohormesis Induced by Exposure to Low Doses of Ionizing Radiation.

Bevelacqua JJ, Mortazavi SMJ.

J Biomed Phys Eng. 2018 Jun 1;8(2):153-156. eCollection 2018 Jun.


Application value of serum biomarkers for choosing memantine therapy for moderate AD.

Wei H, Zhu X, Li Y.

J Neurol. 2018 Aug;265(8):1844-1849. doi: 10.1007/s00415-018-8926-4. Epub 2018 Jun 14.


A novel neuroregenerative approach using ET(B) receptor agonist, IRL-1620, to treat CNS disorders.

Gulati A, Hornick MG, Briyal S, Lavhale MS.

Physiol Res. 2018 Jun 27;67(Supplementum 1):S95-S113. Review.


Cognitive Decline, Dementia, Alzheimer's Disease and Presbycusis: Examination of the Possible Molecular Mechanism.

Shen Y, Ye B, Chen P, Wang Q, Fan C, Shu Y, Xiang M.

Front Neurosci. 2018 Jun 8;12:394. doi: 10.3389/fnins.2018.00394. eCollection 2018. Review.


Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.

Chakraborty A, Chatterjee M, Twaalfhoven H, Del Campo Milan M, Teunissen CE, Scheltens P, Fontijn RD, van Der Flier WM, de Vries HE.

Alzheimers Res Ther. 2018 Jun 23;10(1):58. doi: 10.1186/s13195-018-0385-8.

Supplemental Content

Loading ...
Support Center